RS2891168 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"rs2891168 increases susceptibility to Coronary artery disease 1.30 times for heterozygotes (AG) and ..."
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Type 2 diabetes mellitus or coronary artery disease (pleiotropy) | — | — | 1E-300 | PubMed |
| Coronary artery disease | — | OR: 0.18 | 4E-295 | PubMed |
| Coronary artery disease | A | OR: 0.84 | 5E-278 | PubMed |
| Coronary artery disease | A | OR: 0.19 | 5E-204 | PubMed |
| Myocardial infarction | G | OR: 1.21 | 2E-141 | PubMed |
| Myocardial infarction | G | OR: 0.2 | 2E-120 | PubMed |
| Coronary artery disease (MTAG) | G | β: 0.069 | 8E-111 | PubMed |
| Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | G | OR: 1.19 | 1E-101 | PubMed |
| Coronary artery disease | G | OR: 1.21 | 2E-98 | PubMed |
| Myocardial infarction | G | OR: 1.21 | 5E-75 | PubMed |
| Psycho-cardiometabolic multimorbidity (multivariate analysis) | — | β: 0.092 | 7E-74 | PubMed |
| Myocardial infarction | G | OR: 1.21 | 2E-68 | PubMed |
| Myocardial infarction | G | OR: 0.2 | 7E-53 | PubMed |
| Medication use (vasodilators used in cardiac diseases) | G | OR: 0.15 | 3E-48 | PubMed |
| Abdominal aortic aneurysm | G | OR: 0.2 | 8E-35 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | G | β: 0.054 | 5E-29 | PubMed |
| Medication use (beta blocking agents) | G | β: 0.071 | 4E-18 | PubMed |
| Myocardial infarction (PheCode 411.2) | — | — | 4E-16 | PubMed |
| Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease) | G | β: 0.032 | 3E-9 | PubMed |
| Asthma and cardiovascular disease | — | — | 2E-8 | PubMed |